Company intelligence / Profile preview

SeekGene

Ownership: Private
Development stage: Commercial

Overview

SeekGene specializes in high-throughput single-cell genetic analysis services using proprietary dual-platform technology—microporous chip and water-in-oil droplet systems—for transcriptomics and immune profiling. Their products enable rapid library construction without expensive equipment. They support precision medicine research with robust bioinformatics tools deployed on the cloud. The company’s solutions are widely used in clinical diagnostics, drug development, health management, disease prevention, and personalized medicine.

Modalities: Single-cell RNA sequencing (enabling technology)TCR-pMHC pairing (enabling technology)
Industry: Molecular Diagnostics

Partnerships

AliCloudMemVerge

Beyond the preview

Go deeper on SeekGene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SeekGene.

Explore the full profile